Intravenous immunoglobulin has epigenetic, ribosomal, and immune effects in Paediatric Acute-Onset Neuropsychiatric Syndrome
Preprint
Abstract
Paediatric acute-onset neuropsychiatric syndrome (PANS) is characterised by infection-provoked abrupt and dramatic onset of obsessive compulsive disorder (OCD) or eating restriction, along with neurodevelopmental regression. Although the aetiology of PANS remains uncertain, due to a prevailing neuroimmune hypothesis some children receive the immune modulator intravenous immunoglobulin (IVIg). Using single-cell RNA sequencing of peripheral immune cells, we examined gene expression in five children with PANS (mean age 10.2 years, range 5–17, 60% male) who were receiving open-label IVIg. Maternal autoimmunity (n=3) and familial neurodevelopmental/neuropsychiatric disorders (n=5) were present. The index PANS event occurred age 1.8–13 years, characterised by abrupt eating restriction (n=5), developmental regression (n=4), and OCD (n=3). Single-cell RNA sequencing (144,470 cells) was performed in five patients pre- and post-IVIg, and four controls (mean age 13.5 years, range 11–16, 50% male). In PANS pre-IVIg compared to neurotypical controls, there were downregulated immune pathways (defense response, innate immunity, secretory granules) in most cell types. However, NK cells exhibited upregulated immune pathways (response to corticosteroid), supporting a baseline ‘immune dysregulation’. In PANS pre-IVIg compared to controls, ribosomal pathways were upregulated in neutrophils and CD8 T cells, but downregulated in NK cells. Post-IVIg, the previously downregulated immune pathways were upregulated in most cell types, and the baseline ribosomal pathway abnormalities were reversed. Additionally, histone modification pathways (histone methyltransferase, chromatin) were downregulated in neutrophils and NK cells post-IVIg. We propose PANS is an epigenetic immune-brain disorder with cellular epigenetic, ribosomal, and immune dysregulation. Therefore, epigenetic and immune-modulating therapies, such as IVIg, may have a critical role in treating this disabling disorder. Highlights: Five children with PANS receiving monthly IVIg who had clinical benefit were studied Three young boys had a regressive (autistic) phenotype, whereas the older two girls had OCD Single-cell RNA sequencing showed epigenetic, ribosomal, and immune dysregulation in PANS IVIg treatment had epigenetic and immune-modulating effects in PANS IVIg altered gene expression of histone methyltransferase and chromatin genesKeywords
This publication has 17 references indexed in Scilit:
- Chromatin, transcriptional and immune dysregulation in children with neurodevelopmental regressionmedRxiv, 2025
- A common epigenetic mechanism across different cellular origins underlies systemic immune dysregulation in an idiopathic autism mouse modelMolecular Psychiatry, 2022
- Maternal immune activation and neuroinflammation in human neurodevelopmental disordersNature Reviews Neurology, 2021
- Maternal autoimmunity and inflammation are associated with childhood tics and obsessive-compulsive disorder: Transcriptomic data show common enriched innate immune pathwaysBrain, Behavior, and Immunity, 2021
- Paediatric Acute onset Neuropsychiatric Syndrome: Exploratory study finds no evidence of HLA class II association but high rate of autoimmunity in first‐degree relativesActa Paediatrica, 2021
- Randomized, Controlled Trial of Intravenous Immunoglobulin for Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal InfectionsJournal of the American Academy of Child & Adolescent Psychiatry, 2016
- The histone demethylase JMJD2A/KDM4A links ribosomal RNA transcription to nutrients and growth factors availabilityNature Communications, 2016
- Clinical Evaluation of Youth with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Recommendations from the 2013 PANS Consensus ConferenceJournal of Child and Adolescent Psychopharmacology, 2015
- Synaptic, transcriptional and chromatin genes disrupted in autismNature, 2014
- Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhoodThe Lancet, 1999